Fellner: Celltech's Revenue-Generating Model Key for Biotech
Executive Summary
Peter Fellner, PhD, recently appointed chairman of British Biotech and outgoing CEO of Celltech Group says more of Europe's biotechs need to do what Celltech has done: find a revenue-generating business model.